While mostly prevailing in test cases over coverage for COVID-19 business interruption claims, Insurance Australia Group has asked the High Court to weigh in on what it says is a “radical” approach by an appeals court in the treatment of JobKeeper payments.
The Full Federal Court has appointed a contradictor to “take up the cudgels” against funder Litigation Capital Management, which has challenged a judgment refusing to find that a class action filed against Queensland electricity operators was not a managed investment scheme.
An Emirates-owned provider of in-flight catering services has taken Qantas to court claiming it’s owed $72.5 million after the airline cut its services during the coronavirus pandemic.
Counsel for John Barilaro on Tuesday detailed the online abuse his lawyers faced in acting in a defamation suit over videos posted by commentator Jordan Shanks, as the court heard YouTube owner Google has abandoned its last line of defence in the case.
Convenience store giant 7-Eleven must hand over $595,000 to a franchisee found to have signed a franchise agreement and invested almost $796,000 into a Melbourne store under false pretences.
A judge has censured Domino’s Pizza and the lead applicant in an underpayments class action, saying their lack of cooperation made his “blood boil”.
Former deputy premier of NSW John Barilaro considered “harming himself” after videos were posted by YouTuber Jordan Shanks as part of a “vile and particularly racist smear campaign” facilitated by Google, a court has heard.
Journalist Tegan George will add sex discrimination claims against Network Ten to her lawsuit that alleges harassment and bullying by political journalist Peter van Onselen.
The founder of whitegoods distributor Kleenmaid, who won a retrial after being sentenced to nine years for fraud and insolvent trading, will not spend any more time in jail after being resentenced by a judge who called him “a man of greed”.
The Full Court has upheld two judgments that shortened patent term extensions granted to Merck Sharpe & Dohme and Ono Pharmaceuticals, finding the extension regime cannot be construed as achieving a “commercial outcome for a patentee”.